These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 21701538)

  • 21. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.
    Kurman RJ; Shih IeM
    Am J Surg Pathol; 2010 Mar; 34(3):433-43. PubMed ID: 20154587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon.
    Boyd C; McCluggage WG
    Am J Surg Pathol; 2012 Mar; 36(3):368-75. PubMed ID: 22082603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Observations on the origin of ovarian cortical inclusion cysts in women undergoing risk-reducing salpingo-oophorectomy.
    Park KJ; Patel P; Linkov I; Jotwani A; Kauff N; Pike MC
    Histopathology; 2018 Apr; 72(5):766-776. PubMed ID: 29197096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MORPHOPHENOTYPIC CHARACTERISTICS OF OVARIAN SEROUS BORDERLINE TUMORS.
    Munjishvili V; Barabadze E; Musashvili T; Gachechiladze M; Burkadze G
    Georgian Med News; 2019 May; (290):20-25. PubMed ID: 31322508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of βV-Tubulin in Secretory Cells of the Fallopian Tube Epithelium Marks Cellular Atypia.
    Mathew D; Wang Y; Van Arsdale A; Horwitz SB; McDaid H
    Int J Gynecol Cancer; 2018 Feb; 28(2):363-370. PubMed ID: 29298171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Müllerian system origin?
    Tong GX; Chiriboga L; Hamele-Bena D; Borczuk AC
    Mod Pathol; 2007 Aug; 20(8):856-63. PubMed ID: 17529925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent concepts of ovarian carcinogenesis: type I and type II.
    Koshiyama M; Matsumura N; Konishi I
    Biomed Res Int; 2014; 2014():934261. PubMed ID: 24868556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.
    de Cristofaro T; Di Palma T; Soriano AA; Monticelli A; Affinito O; Cocozza S; Zannini M
    Oncotarget; 2016 Jul; 7(27):41929-41947. PubMed ID: 27259239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery.
    Rabban JT; Garg K; Crawford B; Chen LM; Zaloudek CJ
    Am J Surg Pathol; 2014 Jun; 38(6):729-42. PubMed ID: 24820399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.
    Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ
    J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma.
    Zhang S; Dolgalev I; Zhang T; Ran H; Levine DA; Neel BG
    Nat Commun; 2019 Nov; 10(1):5367. PubMed ID: 31772167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
    Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The morphological and immunohistochemical characteristics of changes in the fallopian tube mucosa in ovarian epithelial tumors].
    Asaturova AV; Ezhova LS; Faizullina NM; Sannikova MV; Khabas GN
    Arkh Patol; 2016; 78(2):3-9. PubMed ID: 27070769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
    O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG
    Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endosalpingiosis as it relates to tubal, ovarian and serous neoplastic tissues: an immunohistochemical study of tubal and Müllerian antigens.
    Esselen KM; Ng SK; Hua Y; White M; Jimenez CA; Welch WR; Drapkin R; Berkowitz RS; Ng SW
    Gynecol Oncol; 2014 Feb; 132(2):316-21. PubMed ID: 24333360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular markers derived from ovarian cancer and its correlation with the types of oviductal epithelial lesions].
    Yuan Y; Zhu W; Gong G; Jiang J; Wang Y; Wu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 May; 44(5):528-534. PubMed ID: 31303616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
    Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
    Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma.
    Chui MH; Wang Y; Wu RC; Seidman J; Kurman RJ; Wang TL; Shih IeM
    Mod Pathol; 2015 Mar; 28(3):437-45. PubMed ID: 25216223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series.
    Morrison JC; Blanco LZ; Vang R; Ronnett BM
    Am J Surg Pathol; 2015 Apr; 39(4):442-53. PubMed ID: 25517955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.